Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule Based on Multicenter Clinical Trials and Omics Mechanisms

NCT07508618 is registered in ClinicalTrials.gov with Sir Run Run Shaw Hospital as lead sponsor.

NCT NCT07508618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07508618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule Based on Multicenter Clinical Trials and Omics Mechanisms
Lead sponsor
Sir Run Run Shaw Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
February 9, 2026
Completion date
August 30, 2027
Enrollment
846 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation